Oxidative stress and inflammatory pathways in dopaminergic neurons

Oxidative stress and inflammatory pathways in dopaminergic neurons represent a multifaceted pathological axis central to the progression of Parkinson's disease (PD). In these neurons, oxidative stress is primarily triggered by the auto-oxidation of dopamine, mitochondrial complex I dysfunction, and high levels of labile iron, leading to the accumulation of reactive oxygen species (ROS) and subsequent lipid, protein, and DNA damage (Hwang, 2013, PubMed: 23575347). This oxidative environment acts as a potent stimulus for neuroinflammation, activating microglia and astrocytes which release pro-inflammatory cytokines like TNF-alpha and IL-1beta, further exacerbating neuronal injury in a self-perpetuating cycle (Glass et al., 2010, PubMed: 20303870). While not a single molecular target, this pathway complex is a major focus for therapeutic intervention, with strategies including the use of monoamine oxidase B (MAO-B) inhibitors to reduce oxidative metabolites and Nrf2 activators to bolster endogenous antioxidant defenses (Youdim et al., 2006, PubMed: 16477050). Effective modulation of these pathways requires addressing the blood-brain barrier and the delicate balance between physiological and pathological signaling (Pajares et al., 2020, PubMed: 32630624).

Other names

Neuroinflammation and oxidative stress in Parkinson's diseaseDopaminergic neurodegeneration pathwaysROS-mediated inflammatory signaling in DA neuronsOxidative-inflammatory axis in the substantia nigra

Reduction of reactive oxygen species (ROS) production, inhibition of pro-inflammatory cytokine release (e.g., TNF-alpha, IL-1beta), activation of the Nrf2-ARE antioxidant signaling pathway, and suppression of microglial M1 phenotypic activation (Hwang, 2013, PubMed: 23575347; Glass et al., 2010, PubMed: 20303870).